Vensana Capital is a venture capital and growth equity investment firm specializing in medical technology innovations. The firm focuses on partnering with entrepreneurs who aim to transform healthcare through breakthrough medtech solutions. Vensana typically invests in Series A to C rounds, with occasional involvement in later-stage and private equity deals.
Notable portfolio companies include Cleerly, Personal Genome Diagnostics, and Relievant Medsystems. Vensana's team brings extensive experience in medtech innovation and is guided by a commitment to supporting healthcare entrepreneurs. The firm's name, derived from "venture" and the Latin root for "health," reflects its dedication to advancing healthcare through strategic investments and partnerships.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
